These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 11308032

  • 41. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.
    Moriggl R, Berchtold S, Friedrich K, Standke GJ, Kammer W, Heim M, Wissler M, Stöcklin E, Gouilleux F, Groner B.
    Mol Cell Biol; 1997 Jul; 17(7):3663-78. PubMed ID: 9199300
    [Abstract] [Full Text] [Related]

  • 42. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts.
    Kriebel P, Patel BK, Nelson SA, Grusby MJ, LaRochelle WJ.
    Oncogene; 1999 Dec 02; 18(51):7294-302. PubMed ID: 10602484
    [Abstract] [Full Text] [Related]

  • 43. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.
    Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y.
    EMBO J; 1999 Mar 01; 18(5):1367-77. PubMed ID: 10064602
    [Abstract] [Full Text] [Related]

  • 44. Control of myeloid differentiation and survival by Stats.
    Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB.
    Oncogene; 2000 May 15; 19(21):2612-8. PubMed ID: 10851060
    [Abstract] [Full Text] [Related]

  • 45. Identification of a STAT6 domain required for IL-4-induced activation of transcription.
    Lu B, Reichel M, Fisher DA, Smith JF, Rothman P.
    J Immunol; 1997 Aug 01; 159(3):1255-64. PubMed ID: 9233621
    [Abstract] [Full Text] [Related]

  • 46. Specific DNA binding and transactivation potential of recombinant, purified Stat5.
    Beisenherz-Huss C, Mundt M, Herrala A, Vihko P, Schubert A, Groner B.
    Mol Cell Endocrinol; 2001 Oct 25; 183(1-2):101-12. PubMed ID: 11604230
    [Abstract] [Full Text] [Related]

  • 47. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription.
    Nakajima H, Brindle PK, Handa M, Ihle JN.
    EMBO J; 2001 Dec 03; 20(23):6836-44. PubMed ID: 11726519
    [Abstract] [Full Text] [Related]

  • 48. A synthetic peptide corresponding to a critical intracellular signaling region of the human IL-4 receptor inhibits IL-4-induced proliferation.
    Izuhara K, Sakai M, Inaba R, Imamura T, Howard M, Harada N.
    Cell Immunol; 1995 Jul 03; 163(2):254-9. PubMed ID: 7606796
    [Abstract] [Full Text] [Related]

  • 49. Accessibility control of TCR Vγ region by STAT5.
    Tani-ichi S, Lee HC, Ye SK, Ikuta K.
    Int Immunol; 2010 Aug 03; 22(8):693-703. PubMed ID: 20547543
    [Abstract] [Full Text] [Related]

  • 50. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K, Leland P, Puri RK.
    Cancer Res; 2000 Jun 01; 60(11):2981-7. PubMed ID: 10850446
    [Abstract] [Full Text] [Related]

  • 51. IL-4 preferentially activates a novel STAT6 isoform in mast cells.
    Sherman MA, Secor VH, Brown MA.
    J Immunol; 1999 Mar 01; 162(5):2703-8. PubMed ID: 10072514
    [Abstract] [Full Text] [Related]

  • 52. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5.
    Nanbu-Wakao R, Morikawa Y, Matsumura I, Masuho Y, Muramatsu MA, Senba E, Wakao H.
    Mol Endocrinol; 2002 Jul 01; 16(7):1565-76. PubMed ID: 12089351
    [Abstract] [Full Text] [Related]

  • 53. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.
    Lin JX, Leonard WJ.
    Oncogene; 2000 May 15; 19(21):2566-76. PubMed ID: 10851055
    [Abstract] [Full Text] [Related]

  • 54. Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.
    Suzuki K, Nakajima H, Kagami S, Suto A, Ikeda K, Hirose K, Hiwasa T, Takeda K, Saito Y, Akira S, Iwamoto I.
    J Exp Med; 2002 Jul 01; 196(1):27-38. PubMed ID: 12093868
    [Abstract] [Full Text] [Related]

  • 55. The role of STATs in myeloid differentiation and leukemia.
    Coffer PJ, Koenderman L, de Groot RP.
    Oncogene; 2000 May 15; 19(21):2511-22. PubMed ID: 10851050
    [Abstract] [Full Text] [Related]

  • 56. Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals.
    Bovolenta C, Camorali L, Mauri M, Ghezzi S, Nozza S, Tambussi G, Lazzarin A, Poli G.
    Clin Immunol; 2001 Apr 15; 99(1):75-81. PubMed ID: 11286543
    [Abstract] [Full Text] [Related]

  • 57. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression.
    Christodoulopoulos P, Cameron L, Nakamura Y, Lemière C, Muro S, Dugas M, Boulet LP, Laviolette M, Olivenstein R, Hamid Q.
    J Allergy Clin Immunol; 2001 Apr 15; 107(4):586-91. PubMed ID: 11295643
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.
    Mora A, Youn J, Keegan A, Boothby M.
    J Immunol; 2001 Feb 15; 166(4):2218-27. PubMed ID: 11160275
    [Abstract] [Full Text] [Related]

  • 60. HIV-1 infection induces a selective reduction in STAT5 protein expression.
    Pericle F, Pinto LA, Hicks S, Kirken RA, Sconocchia G, Rusnak J, Dolan MJ, Shearer GM, Segal DM.
    J Immunol; 1998 Jan 01; 160(1):28-31. PubMed ID: 9551952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.